- Contact 0870 350 7767
- |
- Advertise
Home > Origin Pharma Packaging > ORIGIN PHARMA PACKAGING INVEST IN NEW CLEAN ROOM MANUFACTURING
ORIGIN PHARMA PACKAGING INVEST IN NEW CLEAN ROOM MANUFACTURING
News and PR from Origin Pharma Packaging - Published 17 September 2018
ENHANCING THE HP3 NETWORK
As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative design and production of child safe packaging increase on a global scale.
Our new product development (NPD) team are continually investing their time and knowledge developing commercial solutions for child resistant compliant packaging for the UK, Europe, the U.S.A and beyond.
During the past twenty-four months, Origin Pharma Packaging have partnered custom design and manufacturing projects not compatible with the larger manufacturing sites across the HP3 (Hybrid Pharma Packaging) network. As a result, Origin have added a new clean room manufacturing facility to HP3 network, located in Melton, East Yorkshire, UK.
Origin have executed a multi-million-pound investment programme at our Centre of Excellence for Pharmaceutical Packaging Design & Innovation. Installing and delivering a clean room production facility to ISO 7 (class 10,000) or ISO8 (class 100,000) boosting the capabilities of the existing HP3 network. The facility is equipped for the manufacture of Injection Moulded (IM), Injection Stretch Blow Moulded (ISBM) and Injection Blow Moulded (IBM) parts.
Clean room production facility key facts:
- Classification: ISO7/ class 10,000 to ISO8/ class 100,000
- Compliant to ISO14644 | ISO9001 ISO 15378 | BRC
Processes (all-electric):
- Injection Moulding (IM)
- Injection Stretch Blow Moulding (ISBM)
- Injection Blow Moulding (IBM)
- Automatic Assembly
The HP3 network required the addition of this specific facility at a regional level combining cleanroom classification, multiple ISO and GMP compliance, MHRA pursuit, EUPh compliant raw material sources, custom flexibility and integral supply chain assurance.
Due to the urgency of a sponsor project a global pharmaceuticals manufacturing company Origin executed and delivered the clean room production facility within four months. It is now fully functional, and production commenced in Q1 2018.
Watch the transition of the space into a pharmaceutical, clean room manufacturing facility here:
Our new product development (NPD) team are continually investing their time and knowledge developing commercial solutions for child resistant compliant packaging for the UK, Europe, the U.S.A and beyond.
During the past twenty-four months, Origin Pharma Packaging have partnered custom design and manufacturing projects not compatible with the larger manufacturing sites across the HP3 (Hybrid Pharma Packaging) network. As a result, Origin have added a new clean room manufacturing facility to HP3 network, located in Melton, East Yorkshire, UK.
Origin have executed a multi-million-pound investment programme at our Centre of Excellence for Pharmaceutical Packaging Design & Innovation. Installing and delivering a clean room production facility to ISO 7 (class 10,000) or ISO8 (class 100,000) boosting the capabilities of the existing HP3 network. The facility is equipped for the manufacture of Injection Moulded (IM), Injection Stretch Blow Moulded (ISBM) and Injection Blow Moulded (IBM) parts.
Clean room production facility key facts:
- Classification: ISO7/ class 10,000 to ISO8/ class 100,000
- Compliant to ISO14644 | ISO9001 ISO 15378 | BRC
Processes (all-electric):
- Injection Moulding (IM)
- Injection Stretch Blow Moulding (ISBM)
- Injection Blow Moulding (IBM)
- Automatic Assembly
The HP3 network required the addition of this specific facility at a regional level combining cleanroom classification, multiple ISO and GMP compliance, MHRA pursuit, EUPh compliant raw material sources, custom flexibility and integral supply chain assurance.
Due to the urgency of a sponsor project a global pharmaceuticals manufacturing company Origin executed and delivered the clean room production facility within four months. It is now fully functional, and production commenced in Q1 2018.
Watch the transition of the space into a pharmaceutical, clean room manufacturing facility here:
Our new product development (NPD) team are continually investing their time and knowledge
Other announcements from Origin Pharma Packaging
-
2018: PHARMA TRENDS (PFIZER, FDA, ABBVIE, HUMIRA AND SMART-I)
The pharmaceutical industry plays a crucial role in modern society. Everyone will be affected by medical science and health issues at one time or another.
18 May 2018
-
REVOLUTIONISING HEALTHCARE PACKAGING THROUGH DIGITAL COMMUNICATION
Pioneers in digital packaging, Origin have created Smart-i: Smart packaging technology to enable supply chain visibility and controlling counterfeit medicine products & patient information.
27 Mar 2018